Community-based interventions to prevent fatal overdose from illegal drugs: a systematic review protocol

Chukwudi Okolie1, Bridie Angela Evans1, Ann John1

  • 1College of Medicine, Swansea University, Swansea, UK.

BMJ Open
|November 5, 2015
PubMed
Abstract

Insights

Community-based interventions show promise for preventing drug overdose deaths. This systematic review evaluates their effectiveness in reducing fatalities among individuals misusing illegal drugs.

Area of Science:

  • Public Health
  • Epidemiology
  • Intervention Science

Background:

  • Drug overdose is a leading cause of death for illegal drug users, particularly those who inject drugs.
  • Existing strategies have not sufficiently reduced drug-related mortality.
  • Community-based interventions are a promising avenue for overdose death prevention.

Purpose of the Study:

  • To identify and evaluate published studies on community-based interventions for preventing drug overdose deaths.
  • To assess the effectiveness of these interventions in reducing fatal overdoses.

Main Methods:

  • Systematic literature search of electronic databases (1998-2014) using a four-facet search strategy.
  • Data extraction by two independent reviewers using a standardized table.
  • Quality assessment using the Cochrane Collaboration's risk of bias tool.
  • Meta-analysis for comparable data; narrative synthesis for heterogeneous data.

Main Results:

  • The review will synthesize findings on the effectiveness of various community-based overdose prevention strategies.
  • It will describe the delivery, utilization, and impact of these interventions.
  • Results will quantify effectiveness where possible, or qualitatively describe outcomes.

Conclusions:

  • Findings will inform public health policy and practice regarding community-based overdose prevention.
  • The review aims to identify best practices and areas for improvement in reducing drug overdose deaths.

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
77
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.4K
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
160
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
653
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.4K
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K